文献速递瓣膜外科先天性心脏病外科

技术性能评分可预测先天性二尖瓣修复术后中期死亡与再干预

Technical performance scores are predictors of midterm mortality and reinterventions following congenital mitral valve repair.
PubMed 文献 · Eur J Cardiothorac Surg · 2017-01-01

本研究回顾2000年1月至2013年12月587例先天性二尖瓣修复患者(中位年龄2.6岁),按再干预需求和出院前超声心动图评定技术性能评分(TPS)。TPS 2级和3级与出院后再干预风险增加相关,TPS 3级与无移植生存率降低相关,TPS是中期死亡和再干预的强预测因子。

要点

  • TPS 2级和3级与出院后二尖瓣再干预风险增加独立相关
  • TPS 3级与出院后无移植生存率降低独立相关
  • 出院后二尖瓣再干预与死亡率增加无关

核心结论

  • TPS是先天性二尖瓣修复患者中期死亡和出院后再干预的强预测因子。

研究设计与样本

  • 回顾性队列研究,纳入2000年1月至2013年12月587例二尖瓣修复患者,排除完全性房室间隔缺损一期修复。
  • 根据再干预需求和出院前超声心动图评定TPS:1级无残留,2级轻微残留,3级起搏器植入、严重残留或出院前再干预。
  • 采用Cox比例风险模型和Kaplan-Meier估计进行分析,中位随访3年。

主要发现

  • 出院后再干预125例(21.3%),1年、2年、5年免于再干预率分别为85.2%、78.2%、69.4%。
  • TPS 2级与出院后再干预相关(HR 3.6,95%CI 1.4-10.0,P=0.02)。
  • TPS 3级与出院后再干预相关(HR 8.7,95%CI 3.0-25.1,P<0.001)。
  • 晚期死亡/移植31例,1年、2年、5年无移植生存率分别为97.8%、95.3%、93.2%。
  • TPS 3级与出院后无移植生存率降低相关(HR 5.5,95%CI 1.2-25.0,P=0.03)。

关键数值与推荐

  • TPS分级标准:1级无残留;2级轻微残留;3级起搏器植入、严重残留或出院前再干预。

临床怎么用

  • 对先天性二尖瓣修复患者,可根据TPS分级识别中期死亡和再干预高风险者,加强随访。

局限性

  • 回顾性研究设计。
  • 单中心研究。
  • 中位随访时间3年。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The Technical Performance Score (TPS) has been shown to be predictive of postoperative mortality, morbidities and reinterventions following various cardiac procedures in children. We hypothesized that TPS is also a predictor of mitral valve repair outcomes. METHODS: A review of patients who underwent mitral valve repair from January 2000 to December 2013 was performed. Primary repair of complete atrioventricular defect was excluded. The scores were determined according to previously published criteria based on the need for reintervention and predischarge echocardiograms: Class 1 (no residua), Class 2 (minor residua) or Class 3 (pacemaker implantation, major residua or reintervention for major residua prior to discharge). Cox proportional hazard models and Kaplan-Meier estimator were used. RESULTS: A total of 587 patients underwent mitral repair (median age 2.6 years). Median follow-up duration was 3 years. There were 125 (21.3%) post-discharge mitral reinterventions and freedom from reintervention was 85.2%, 78.2% and 69.4% at 1, 2 and 5 years, respectively. Both TPS Class 2 [hazard ratio (HR) 3.6, 95% confidence interval (CI) 1.4-10.0; P = 0.02] and Class 3 (HR 8.7, 95% CI 3.0-25.1; P < 0.001) were associated with post-discharge reinterventions. There were 31 late deaths/transplantations, and transplant-free survival at 1, 2 and 5 years was 97.8%, 95.3% and 93.2%. TPS 3 was associated with decreased post-discharge transplant-free survival (HR 5.5, 95% CI 1.2-25.0; P = 0.03). Post-discharge mitral reintervention was not associated with increased mortality. CONCLUSIONS: The TPS is a strong predictor of midterm mortality and post-discharge mitral reintervention in congenital patients who underwent mitral repair.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Martin E, Del Nido PJ, Nathan M, et al. Technical performance scores are predictors of midterm mortality and reinterventions following congenital mitral valve repair. Eur J Cardiothorac Surg. 2017. PMID: 28398542. doi:10.1093/ejcts/ezx074

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。